Pasithea Therapeutics Corp. (KTTA) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -4.79M | -5.4M | -2.89M | -3.87M | -3.06M | -2.44M | -3.12M | -4.04M | -4.32M | -3.29M | -3.25M | -3.48M | -3.39M | -4.42M | -4.22M | -1.92M | -2.53M | -1.74M | -548.44K | -499.44K |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -11581.02% | - | - |
| Operating CF Growth % | -56.66% | -120.91% | 7.38% | 4.21% | 29.28% | 25.84% | 3.96% | -16.08% | -27.63% | 25.45% | 23.03% | -80.77% | -33.96% | -153.32% | -669.64% | -285.38% | -561.91% | - | - | - |
| Net Income | -2.87M | -2.84B | -3.04M | -3.72M | -3.56M | -3.18M | -3M | -3.87M | -3.86M | -5.03M | -3.61M | -3.6M | -3.27M | -5.12M | -4.19M | -2.66M | -1.57M | 630.12K | -1.53M | -727.95K |
| Depreciation & Amortization | 157.54K | -8.05M | 181.54K | 161.75K | 161.71K | 162.26K | 162.26K | 162.26K | 162.26K | 162.22K | 162.26K | 162.26K | 161.72K | -97 | -1 | 957 | 5.01K | 1.38K | 0 | 0 |
| Stock-Based Compensation | 0 | -67.77M | 0 | 57.65K | 98.56K | 118.38K | 147.88K | 160.95K | 346.48K | 69.94K | 126.67K | 218.63K | 177.02K | 156.17K | -16.07K | 100K | 135.63K | 156.59K | 15K | 299.67K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.59M | 0 | 0 |
| Other Non-Cash Items | -1.4M | 2.91B | 109.08K | 8.19K | -69.04K | -1.41K | 70.31K | 35.62K | -26.72K | 52.43K | -55.29K | -577.2K | -135.61K | -482.79K | 735.87K | 547.25K | -785.3K | -32.51K | 1.28M | -282.86K |
| Working Capital Changes | -672.33K | -64.05K | -143.23K | -380.31K | 316.26K | 455.39K | -501.06K | -531.45K | -942.26K | 1.45M | 129.85K | 315.04K | -323.04K | 1.03M | -749.8K | 85.46K | -308.58K | 86.49K | -322.19K | 211.7K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -15.78K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -13.6K | 440.68K | 0 | 0 |
| Cash from Investing | 0 | 11K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 54.54K | 50.16K | 344.01K | -49.7K | -1.76M | -185.92K | -468.71K | -113.87K | -12.93K | -8.57K | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 36 | 22.66K | -3.11K | -53.89K | -25.27K | -5.49K | -6.94K | -113.87K | -12.93K | -8.57K | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 85.87% | - | - |
| Acquisitions | 0 | 11K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 32.98K | -20.48K | 77.06K | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 54.5K | 27.5K | 347.12K | 4.19K | -1.76M | -159.96K | -538.84K | 0 | 0 | 0 | 0 |
| Cash from Financing | 750 | 56.42M | -116.14K | 5.74M | 1.47M | -23.55K | 4.54M | 0 | 0 | -16.89K | -3.86M | -130.77K | 264.1K | -3.21M | -1.03M | 106.54K | 0 | 34.17M | 20.55M | 0 |
| Debt Issued (Net) | 0 | 408.97K | -116.14K | -113.51K | -179.31K | 0 | 0 | 0 | 0 | 0 | -133.34K | -130.77K | 264.1K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 750 | 56.46M | 0 | 5.85M | 1.65M | -23.55K | 4.54M | 0 | 0 | 0 | 0 | 0 | 0 | -3.21M | 0 | 0 | 0 | 27.17M | 21.86M | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -448.28K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -16.89K | -3.73M | 0 | 0 | 0 | -1.03M | 106.54K | 0 | 7M | -1.31M | 0 |
| Net Change in Cash | -4.76M | 51.04M | -2.99M | 1.88M | -1.58M | -2.44M | 1.39M | -4.04M | -4.32M | -3.25M | -7.06M | -3.27M | -3.17M | -9.25M | -5.52M | -2.33M | -2.65M | 32.4M | 20M | -501.75K |
| Free Cash Flow | -4.79M | -5.4M | -2.89M | -3.87M | -3.06M | -2.44M | -3.12M | -4.04M | -4.32M | -3.29M | -3.23M | -3.48M | -3.44M | -6.21M | -4.23M | -1.93M | -2.64M | -1.76M | -557.01K | -499.44K |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -11666.88% | - | - |
| FCF Growth % | -56.66% | -120.91% | 7.38% | 4.21% | 29.28% | 25.84% | 3.28% | -15.98% | -25.63% | 46.93% | 23.66% | -80.28% | -30.22% | -253.26% | -658.79% | -286.77% | -591.74% | - | - | - |
| FCF per Share | -0.68 | -0.77 | -0.39 | -0.69 | -2.79 | -2.23 | -2.99 | -3.87 | -4.15 | -3.16 | -2.56 | -2.67 | -2.64 | -4.77 | -3.18 | -1.65 | -2.30 | -1.53 | -0.84 | -0.72 |
| FCF Conversion (FCF/Net Income) | 1.67x | 0.53x | 0.95x | 1.04x | 0.86x | 0.77x | 1.04x | 1.04x | 1.12x | 0.65x | 0.90x | 0.92x | 0.96x | 0.86x | 0.92x | 0.72x | -61.12x | -2.77x | 0.36x | 0.69x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |